Columbia Research Enhanced Value ETF Rating $27.60 +0.02 (+0.07%) Closing price 04:10 PM EasternExtended Trading$27.60 -0.01 (-0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Columbia Research Enhanced Value ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.REVS Aggregate RatingModerate Buy 2.59Holdings in REVS have an aggregate rating of Moderate Buy based on 586 analyst ratings issued in the past year covering 23 companies (41.2% of the portfolio).REVS Aggregate Price Target$27.57-0.11% DownsideHigh Prediction$27.57Average Prediction$27.57Low Prediction$27.57Holdings in REVS have an aggregate price target of $27.57 and a range of $27.57 to $27.57 covering 23 companies (41.2% of the portfolio).REVS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Columbia Research Enhanced Value ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 REVS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.39%JPMJPMorgan Chase & Co.$298.60+1.3%4.7242 of 5 stars2.52$288.68 -3.3%23Trending News2.48%PFEPfizer$24.97-0.7%4.8749 of 5 stars2.39$28.12 12.6%18Trending News2.46%CSCOCisco Systems$68.39+1.9%4.8109 of 5 stars2.63$74.53 9.0%24Positive News2.27%XOMExxon Mobil$111.710.0%4.9329 of 5 stars2.43$125.00 11.9%21Trending NewsAnalyst UpgradeInsider Trade2.21%MOAltria Group$66.54-0.8%4.1726 of 5 stars2.00$60.88 -8.5%9Positive NewsDividend Increase1.91%LOWLowe's Companies$258.42-0.2%4.7476 of 5 stars2.58$283.92 9.9%26Earnings ReportAnalyst Revision1.91%CRMSalesforce$244.26-1.5%4.9706 of 5 stars2.76$340.54 39.4%41Trending NewsAnalyst ForecastInsider Trade1.80%GOOGLAlphabet$207.14-0.6%4.0173 of 5 stars2.86$211.53 2.1%43Trending News1.78%BLKBlackRock$1,140.55+0.3%4.78 of 5 stars2.80$1,151.21 0.9%15Trending News1.69%CATCaterpillar$431.05-0.3%4.6971 of 5 stars2.83$450.87 4.6%18Trending News1.67%MSMorgan Stanley$148.96+0.9%4.358 of 5 stars2.47$138.25 -7.2%15Trending News1.53%CVSCVS Health$71.57+0.5%4.9683 of 5 stars3.05$77.56 8.4%22Positive NewsAnalyst Forecast1.47%GOOGAlphabet$207.95-0.6%4.6527 of 5 stars2.77$215.19 3.5%31Trending News1.45%CCitigroup$95.63+0.7%4.9329 of 5 stars2.67$96.54 0.9%15Trending News1.44%CVXChevron$157.43-0.5%4.7016 of 5 stars2.36$163.95 4.1%22Positive News1.41%BMYBristol Myers Squibb$47.25+0.2%4.8048 of 5 stars2.24$56.38 19.3%211.30%QCOMQUALCOMM$159.17+1.8%4.954 of 5 stars2.48$182.82 14.9%23Positive NewsAnalyst Upgrade1.26%CICigna Group$300.38-0.1%5 of 5 stars3.00$374.82 24.8%19Positive NewsAnalyst Forecast1.24%NKENIKE$78.74-0.5%4.505 of 5 stars2.72$78.22 -0.7%32Positive News1.24%METAMeta Platforms$754.10+0.1%4.1831 of 5 stars2.96$822.41 9.1%47Trending NewsAnalyst Revision1.23%UNPUnion Pacific$222.86-0.2%4.8199 of 5 stars2.56$258.21 15.9%27Positive News1.08%AMDAdvanced Micro Devices$166.62+2.0%4.3791 of 5 stars2.76$181.33 8.8%38Trending NewsAnalyst UpgradeInsider Trade0.98%TGTTarget$96.19-1.0%4.9518 of 5 stars2.19$113.74 18.2%36Earnings ReportAnalyst Revision This page (NYSEARCA:REVS) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access